基本信息
views: 34
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
长期从事临床以及教学及科研工作,承担国家自然科学基金2项。作为PI/Sub—PI参与60余项国际/国内多项新药临床研究。第一和通讯作者SCI 28篇。任华中科技大学(医学)外文版,Oncology and Translational Medicine编委,内科急危重症杂志编委。共同主编《血液肿瘤精准诊疗及方案解读》, 参编《血栓与止血》、《白血病基础与临床》等8部。目前社会任职:中国医学教育协会白血病分会常委,中国研究型医院协会血栓与止血专委会常委,中国老年医学学会血液学分会委员,中国抗癌协会髓系肿瘤学组委员,亚太医学生物免疫学会血液学分会常务委员,湖北医学生物免疫学会血液专委会常务委员,湖北省ESCO淋巴瘤专委会常务委员,《血栓与止血学》杂志第七届常务编委
Research Interests
Papers共 181 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CLINICAL CANCER RESEARCHno. 7 (2024): 1248-1255
Yuqin Song,Zhengming Jin,Zhi-Ming Li,Yanyan Liu,Lanfang Li,Chuan He,Hang Su,Hui Zhou,Kunyan Li, Siguo Hao, Xuelan Zuo,Jianyuan Wu,
crossref(2024)
Yuqin Song,Zhengming Jin,Zhi-Ming Li,Yanyan Liu,Lanfang Li, Chuan He,Hang Su,Hui Zhou,Kunyan Li, Siguo Hao, Xuelan Zuo,Jianyuan Wu,
crossref(2024)
Yuqin Song,Zhengming Jin,Zhi-Ming Li,Yanyan Liu,Lanfang Li,Chuan He,Hang Su,Hui Zhou,Kunyan Li, Siguo Hao, Xuelan Zuo,Jianyuan Wu,
crossref(2024)
Annals of Hematologypp.1-12, (2024)
Yuqin Song,Zhengming Jin,Zhi-Ming Li,Yanyan Liu,Lanfang Li, Chuan He,Hang Su,Hui Zhou,Kunyan Li, Siguo Hao, Xuelan Zuo,Jianyuan Wu,
crossref(2024)
Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yuqin Song,Zhengming Jin,Zhi-Ming Li,Yanyan Liu,Lanfang Li, Chuan He,Hang Su,Hui Zhou,Kunyan Li, Siguo Hao, Xuelan Zuo,Jianyuan Wu,
crossref(2024)
Yuqin Song,Zhengming Jin,Zhi-Ming Li,Yanyan Liu,Lanfang Li, Chuan He,Hang Su,Hui Zhou,Kunyan Li, Siguo Hao, Xuelan Zuo,Jianyuan Wu,
crossref(2024)
EXPERT REVIEW OF HEMATOLOGYno. 4-5 (2024): 173-180
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn